Cargando…

A retrospective study of adverse drug events in anticoagulant administration with relevance to COVID-19()

Initial studies in COVID-19 patients reported lower mortality rates associated with the use of the drug heparin, a widely used anticoagulant. The objective of this analysis was to determine whether there are adverse events associated with the administration of anticoagulants, and specifically how th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Patel, Purva, Gaddis, Monica, Xu, Xuan, Riviere, Jim E., Kawakami, Jessica, Meyer, Emma, Jaberi-Douraki, Majid, Wyckoff, Gerald J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9951606/ https://www.ncbi.nlm.nih.gov/pubmed/36855650 http://dx.doi.org/10.1016/j.heliyon.2023.e13763

Ejemplares similares

Pulmonary adverse drug event data in hypertension with implications on COVID-19 morbidity
por: Jaberi-Douraki, Majid, et al.
Publicado: (2021)

Pharmacovigilance in patients with diabetes: A data-driven analysis identifying specific RAS antagonists with adverse pulmonary safety profiles that have implications for COVID-19 morbidity and mortality
por: Stafford, Emma G., et al.
Publicado: (2020)

Data mining methodology for response to hypertension symptomology—application to COVID-19-related pharmacovigilance
por: Xu, Xuan, et al.
Publicado: (2021)

Predicting the Prognostic Value of POLI Expression in Different Cancers via a Machine Learning Approach
por: Xu, Xuan, et al.
Publicado: (2022)

An Automated Customizable Live Web Crawler for Curation of Comparative Pharmacokinetic Data: An Intelligent Compilation of Research-Based Comprehensive Article Repository
por: Ampadi Ramachandran, Remya, et al.
Publicado: (2023)

Optimality of a time-dependent treatment profile during an epidemic
por: Jaberi-Douraki, Majid, et al.
Publicado: (2013)

Predictive Models of Type 1 Diabetes Progression: Understanding T-Cell Cycles and Their Implications on Autoantibody Release
por: Jaberi-Douraki, Majid, et al.
Publicado: (2014)

Hybrid computational modeling demonstrates the utility of simulating complex cellular networks in type 1 diabetes
por: Shi, Zhenzhen, et al.
Publicado: (2021)

Mortality and oral anticoagulants in the Food and Drug Administration Adverse Event Reporting System
por: Serebruany, Victor, et al.
Publicado: (2017)

Risk of influenza infection with low vaccine effectiveness: the role of avoidance behaviour
por: Vilches, Thomas N., et al.
Publicado: (2019)

Global Trends in Cancer Nanotechnology: A Qualitative Scientific Mapping Using Content-Based and Bibliometric Features for Machine Learning Text Classification
por: Millagaha Gedara, Nuwan Indika, et al.
Publicado: (2021)

Mathematical modeling of the ‘inoculum effect': six applicable models and the MIC advancement point concept
por: Salas, Jessica R, et al.
Publicado: (2020)

Comparative Molecular Immunological Activity of Physiological Metal Oxide Nanoparticle and its Anticancer Peptide and RNA Complexes
por: DeLong, Robert K., et al.
Publicado: (2019)

Characteristics of ambulatory anticoagulant adverse drug events: a descriptive study
por: Long, Andrea L, et al.
Publicado: (2010)

COVID-19 vaccine immune response in patients with plasma cell dyscrasia: a systematic review
por: Faizan, Unaiza, et al.
Publicado: (2023)

Prevention of adverse events in the administration of drugs
por: Diano, G, et al.
Publicado: (2010)

Adverse reaction profiles of hemorrhagic adverse reactions caused by direct oral anticoagulants analyzed using the Food and Drug Administration Adverse Event Reporting System (FAERS) database and the Japanese Adverse Drug Event Report (JADER) database
por: Shimada, Kazuyo, et al.
Publicado: (2019)

Large-Scale Data Mining of Rapid Residue Detection Assay Data From HTML and PDF Documents: Improving Data Access and Visualization for Veterinarians
por: Jaberi-Douraki, Majid, et al.
Publicado: (2021)

Hyperglycemic adverse events following antipsychotic drug administration in spontaneous adverse event reports
por: Kato, Yamato, et al.
Publicado: (2015)

Adverse Events and Mortality in Anticoagulated Patients with Different Categories of Pulmonary Embolism
por: Cambron, Julia C., et al.
Publicado: (2020)

Insurance Does Not Affect Adverse Events While Awaiting Surgery for Ankle Trauma in One System
por: Dobbins, Adam B., et al.
Publicado: (2020)

Establishing Statistical Equivalence of Data from Different Sampling Approaches for Assessment of Bacterial Phenotypic Antimicrobial Resistance
por: Shakeri, Heman, et al.
Publicado: (2018)

Neurological adverse events following regional anesthesia administration
por: Kent, Christopher D, et al.
Publicado: (2010)

271 Evaluation of Adverse Events Associated to Administration of Omalizumab
por: Gomez, R. Maximiliano, et al.
Publicado: (2012)

Reporting adverse drug events to the Therapeutic Goods Administration
por: Martin, Jennifer H, et al.
Publicado: (2021)

Prediction of clinically relevant adverse drug events in surgical patients
por: Bos, Jacqueline M., et al.
Publicado: (2018)

Serosurvey of Human Antibodies Recognizing Aedes aegypti D7 Salivary Proteins in Colombia
por: Londono-Renteria, Berlin L., et al.
Publicado: (2018)

Targeting SARS-CoV-2 Variants with Nucleic Acid Therapeutic Nanoparticle Conjugates
por: Huber, Hanah F., et al.
Publicado: (2021)

Automatically Recognizing Medication and Adverse Event Information From Food and Drug Administration’s Adverse Event Reporting System Narratives
por: Polepalli Ramesh, Balaji, et al.
Publicado: (2014)

META-INSTI: metabolic adverse events following integrase strand transfer inhibitor administration in spontaneous adverse event reports
por: Murray, Milena M, et al.
Publicado: (2023)

Adverse events in patients initiated on dabigatran etexilate therapy in a pharmacist-managed anticoagulation clinic
por: Donaldson, Mark, et al.
Publicado: (2013)

Non-bleeding Adverse Events with the Use of Direct Oral Anticoagulants: A Sequence Symmetry Analysis
por: Maura, Géric, et al.
Publicado: (2018)

Potential Reduction in Adverse Events and Cost with Novel Anticoagulants among Patients with Acute Limb Ischemia
por: Freeman, Scott, et al.
Publicado: (2022)

Fatal Events in Cancer Patients Receiving Anticoagulant Therapy for Venous Thromboembolism
por: Farge, Dominique, et al.
Publicado: (2015)

Adverse Events Associated with Administration of Simulation Intravenous Fluids to Patients — United States, 2014
por: Robyn, Misha P., et al.
Publicado: (2015)

Geriatric Patient Safety Indicators Based on Linked Administrative Health Data to Assess Anticoagulant-Related Thromboembolic and Hemorrhagic Adverse Events in Older Inpatients: A Study Proposal
por: Le Pogam, Marie-Annick, et al.
Publicado: (2017)

Spontaneous Reporting on Adverse Events by Consumers in the United States: An Analysis of the Food and Drug Administration Adverse Event Reporting System Database
por: Toki, Tadashi, et al.
Publicado: (2018)

Adverse Events Associated With the Use of Sipuleucel-T Reported to the US Food and Drug Administration’s Adverse Event Reporting System, 2010-2017
por: Dores, Graça M., et al.
Publicado: (2019)

106. META-INSTI: Metabolic Adverse Events Following Integrase Strand Transfer Inhibitor Administration in Spontaneous Adverse Event Reports
por: Murray, Milena M, et al.
Publicado: (2020)

Adverse events associated with molnupiravir: a real-world disproportionality analysis in food and drug administration adverse event reporting system
por: Liang, Yankun, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_vonei5810b5e5nus9kj0oafuqn